Australia's CSL in mRNA vaccine licensing deal with U.S.-based Arcturus | Financial Post

Retrieved on: 2022-11-02 02:04:19

Tags for this article:

Click the tags to see associated articles and topics

Australia's CSL in mRNA vaccine licensing deal with U.S.-based Arcturus | Financial Post. View article details on hiswai:

Excerpt

The biopharmaceutical firm said it would pay Arcturus $200 million upfront in return for an exclusive license to its next generation mRNA ...

Article found on: financialpost.com